Topics

Glioblastoma | Treatment | Targeted therapy | BRAF-MEK-inhibitors

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > BRAF-MEK-inhibitors

Steininger J, Buszello C, Oertel R, Meinhardt M, Schmid S, Engellandt K, Herold S, Stasik S, Ebrahimi A, Renner B, Thiede C, Eyüpoglu IY, Schackert G, Beissert S, Meier F, Radke J, Westphal D, Juratli TA.
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.
Acta Neuropathol Commun. 2024 Aug 6;12(1):124. doi: 10.1186/s40478-024-01834-8. PMID: 39107839. Case report. ˍ

Homma T, Suzuki T, Kato T, Shirahata M, Mishima K.
Cerebrospinal fluid cytology in a case of epithelioid glioblastoma.
Cytopathology. 2024 Aug 13. doi: 10.1111/cyt.13436. PMID: 39136219. Case report. ˍ

Vrachas D, Kosma E, Giannopoulou AI, Margoni A, Gargalionis AN, El-Habr EA, Piperi C, Adamopoulos C.
Targeting the MAPK Pathway in Brain Tumors: Mechanisms and Therapeutic Opportunities.
Cancers (Basel). 2026 Jan 2;18(1):156. doi: 10.3390/cancers18010156. PMID: 41514664. Review. ˍ